Weight loss medicines in England
A briefing on the licensing, regulation and supply of new weight loss medications in England.

This pack has been prepared ahead of the debate to be held in the Commons Chamber on Thursday 24 January 2019 on appropriate ME treatment. The subject for this debate has been determined by the Backbench Business Committee.
Commons Library debate pack - Appropriate ME treatment (373 KB , PDF)
A debate on appropriate ME treatment will be held in the Commons chamber on 24 January 2019. The subject of the debate was decided by the Backbench Business Committee, and the debate will be led by Carol Monaghan MP, Nicky Morgan MP and Ben Lake MP.
The motion of the debate is:
That this House calls on the Government to provide increased funding for biomedical research for the diagnosis and treatment of ME, supports the suspension of Graded Exercise Therapy and Cognitive Behaviour Therapy as means of treatment, supports updated training of GPs and medical professionals to ensure that they are equipped with clear guidance on the diagnosis of ME and appropriate management advice to reflect international consensus on best practice, and is concerned about the current trends of subjecting ME families to unjustified child protection procedures.
Commons Library debate pack - Appropriate ME treatment (373 KB , PDF)
A briefing on the licensing, regulation and supply of new weight loss medications in England.
Find out about the causes and consequences of medicines shortages, and UK Government actions in response to supply disruption affecting human medicines.
Interactive dashboard showing data on GPs in England, including patient to GP ratios, the number of GPs, and a map of GP practices